EDGAR Filing Documents for 0001193125-09-157059

Form 8-K - Current report:

SEC Accession No. 0001193125-09-157059

Filing Date

2009-07-28

Accepted

2009-07-28 17:20:41

Documents

Period of Report

2009-07-22

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	20590
2	UNDERWRITING AGREEMENT, DATED JULY 22, 2009	dex11.htm	EX-1.1	124059
3	FORM OF COMMON STOCK PURCHASE WARRANT	dex41.htm	EX-4.1	61006
4	OPINION OF KARR TUTTLE CAMPBELL	dex51.htm	EX-5.1	12039
5	PRESS RELEASE	dex991.htm	EX-99.1	8895
6	GRAPHIC	g77952g58s73.jpg	GRAPHIC	3117
7	GRAPHIC	g77952g68x26.jpg	GRAPHIC	4903
	Complete submission text file	0001193125-09-157059.txt		239565

Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119

Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100

CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)